Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aldurazyme in Mucopolysaccharidosis I
NCT00912925Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2000
- Primary completion
- Sep 2001
- Modality
- Replacement Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of laronidase in mucopolysaccharidosis type I, sponsored by Sanofi. Started Dec 2000; status: completed.
02
Drugs
laronidase
03
Conditions
mucopolysaccharidosis type I
Beyond the preview
Go deeper on NCT00912925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00912925.